Literature DB >> 3120472

Transfusion and exchange transfusion in sickle cell anaemias, with particular reference to iron metabolism.

J B Porter1, E R Huehns.   

Abstract

The relationship between the number of units of blood transfused and indicators of iron status in 37 patients with sickle cell anaemia (Hb SS), SC disease (Hb SC) or S beta-thalassaemia has been studied. The correlation coefficient between serum ferritin and the number of units transfused was good (r = 0.86), provided that ferritin samples taken within one week following a crisis were excluded. The relationship of transfusion history to serum ferritin in the steady state showed a similar relationship to that previously observed for other multiply transfused patients. The serum ferritin taken within 7 days of a painful crisis was significantly greater than the serum ferritin from the same patients in the steady state (p less than 0.025). The serum alanine transaminase did not rise as consistently as the serum ferritin during crises; it correlated with the serum ferritin but not the transfusion burden in the steady state. Transferrin iron saturation correlated less clearly with transfusion history than serum ferritin (r = 0.62). Patients who had received exchange transfusions were less likely to be iron-overloaded (ferritin increment per unit of blood = 9.9 +/- 3.8 micrograms/l) than patients who had received an equivalent number of units by conventional transfusion (ferritin increment per unit of blood transfused = 25.1 +/- 2.42 micrograms/l).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3120472     DOI: 10.1159/000205875

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  9 in total

Review 1.  Synthetic and natural iron chelators: therapeutic potential and clinical use.

Authors:  Heather C Hatcher; Ravi N Singh; Frank M Torti; Suzy V Torti
Journal:  Future Med Chem       Date:  2009-12       Impact factor: 3.808

Review 2.  Sickle cell disease: when and how to transfuse.

Authors:  Jo Howard
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 3.  Pediatric transfusion therapy: practical considerations.

Authors:  R Kulkarni; R Gera
Journal:  Indian J Pediatr       Date:  1999 May-Jun       Impact factor: 1.967

4.  Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias.

Authors:  Maria Domenica Cappellini; John Porter; Amal El-Beshlawy; Chi-Kong Li; John F Seymour; Mohsen Elalfy; Norbert Gattermann; Stéphane Giraudier; Jong-Wook Lee; Lee Lee Chan; Kai-Hsin Lin; Christian Rose; Ali Taher; Swee Lay Thein; Vip Viprakasit; Dany Habr; Gabor Domokos; Bernard Roubert; Antonis Kattamis
Journal:  Haematologica       Date:  2009-11-30       Impact factor: 9.941

5.  Exacerbation of sickle cell disease itself as a cause of abnormal liver chemistry tests.

Authors:  Carmen M Stanca; Maria Isabel Fiel; Thomas D Schiano
Journal:  Dig Dis Sci       Date:  2006-12-15       Impact factor: 3.487

6.  [Digestives diseases associated to sickle cell anemia in Lubumbashi: epidemiological and clinical aspects].

Authors:  Manix Ilunga Banza; Jules Panda Mulefu; Lire Ipani Lire; Yannick Tietie Ben N'dwala; Israel Badypwyla Tshiamala; Vincent de Paul Kaoma Cabala
Journal:  Pan Afr Med J       Date:  2019-07-26

7.  Model-Based Optimisation of Deferoxamine Chelation Therapy.

Authors:  Francesco Bellanti; Giovanni C Del Vecchio; Maria C Putti; Carlo Cosmi; Ilaria Fotzi; Suruchi D Bakshi; Meindert Danhof; Oscar Della Pasqua
Journal:  Pharm Res       Date:  2015-11-10       Impact factor: 4.200

8.  The Iron Status of Sickle Cell Anaemia Patients in Ilorin, North Central Nigeria.

Authors:  Musa A Sani; James O Adewuyi; Abiola S Babatunde; Hannah O Olawumi; Rasaki O Shittu
Journal:  Adv Hematol       Date:  2015-10-15

9.  Biopsy-based calibration of T2* magnetic resonance for estimation of liver iron concentration and comparison with R2 Ferriscan.

Authors:  Maciej W Garbowski; John-Paul Carpenter; Gillian Smith; Michael Roughton; Mohammed H Alam; Taigang He; Dudley J Pennell; John B Porter
Journal:  J Cardiovasc Magn Reson       Date:  2014-06-10       Impact factor: 5.364

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.